Thompson Siegel & Walmsley LLC Dexcom Inc Transaction History

Thompson Siegel & Walmsley LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$86.06 - $137.93 $44,406 - $71,171	516 New	516 $48,000
Q2 2022 Jul 22, 2022	BUY	$67.99 - $132.89 $2,855 - $5,581	42 Added 300.0%	56 $4,000
Q1 2022 Apr 26, 2022	BUY	$94.08 - $130.2 $1,317 - $1,822	14 New	14 $7,000
Q1 2020 May 12, 2020	SELL	$47.79 - $75.63 $95,580 - $151,260	-2,000 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$36.62 - $57.29 $73,240 - $114,580	2,000 New	2,000 $437,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.